MGB-BP-3: Clinical Trials

2 trials of MGB-BP-3, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow MGB-BP-3: new trials by email Literature Review of MGB-BP-3 trials Research Report on MGB-BP-3

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD
MGB-BP-3 - Clostridium Difficile Infection
Phase 2CompletedMGB Biopharma Limited342019-02-072020-04-15
Safety, Blood Levels and Effects of MGB-BP-3
MGB-BP-3, Placebo - Healthy
Phase 1CompletedMGB Biopharma Limited402015-07-012016-03-17

Conditions studied

Clostridium Infections (1)

Sponsors

MGB Biopharma Limited (2)

Countries

Canada (1)  ·  United States (1)

Top investigators

Malcolm Boyce, Various (1)  ·  Miroslav Ravic, MD (1)

NIH funding

2015 (2)